» Articles » PMID: 37962646

Circulating Serotonin and Dopamine Concentrations in Osteoarthritis Patients: a Pilot Study on the Effect of Pelotherapy

Overview
Specialty Biophysics
Date 2023 Nov 14
PMID 37962646
Authors
Affiliations
Soon will be listed here.
Abstract

Balneotherapy has demonstrated clinical efficacy in the management of pathologies involving low-grade inflammation and stress. In rheumatic conditions such as osteoarthritis (OA), this therapy presents anti-inflammatory properties and potential to improve psychological well-being. Although the neurohormones serotonin and dopamine are known to be involved in these processes, surprisingly they have not been studied in this context. The objective was to evaluate the effect of a cycle of balneotherapy with peloids (pelotherapy) on circulating serotonin and dopamine concentrations in a group of aged individuals with OA, after comparing their basal state to that of an age-matched control group. In our pilot study, a pelotherapy program (10 days) was carried out in a group of 16 elderly patients with OA, evaluating its effects on circulating serotonin and dopamine concentrations (measured by ELISA). Individuals with OA showed higher levels of serotonin and lower dopamine levels, in line with the inflammatory roles of these mediators. After pelotherapy, serotonin concentrations significantly decreased, potentially contributing to the previously reported anti-inflammatory effects of balneotherapy.

References
1.
Galvez I, Torres-Piles S, Hinchado M, Alvarez-Barrientos A, Torralbo-Jimenez P, Guerrero J . Immune-Neuroendocrine Dysregulation in Patients with Osteoarthritis: A Revision and a Pilot Study. Endocr Metab Immune Disord Drug Targets. 2017; 17(1):78-85. DOI: 10.2174/1871530317666170320113613. View

2.
Capellino S, Cosentino M, Luini A, Bombelli R, Lowin T, Cutolo M . Increased expression of dopamine receptors in synovial fibroblasts from patients with rheumatoid arthritis: inhibitory effects of dopamine on interleukin-8 and interleukin-6. Arthritis Rheumatol. 2014; 66(10):2685-93. DOI: 10.1002/art.38746. View

3.
Igari T, Tsuchizawa M, Shimamura T . Alteration of tryptophan metabolism in the synovial fluid of patients with rheumatoid arthritis and osteoarthritis. Tohoku J Exp Med. 1987; 153(2):79-86. DOI: 10.1620/tjem.153.79. View

4.
Schwendich E, Salinas Tejedor L, Schmitz G, Rickert M, Steinmeyer J, Rehart S . Modulation of Dopamine Receptors on Osteoblasts as a Possible Therapeutic Strategy for Inducing Bone Formation in Arthritis. Cells. 2022; 11(10). PMC: 9140103. DOI: 10.3390/cells11101609. View

5.
Feng Y, Lu Y . Immunomodulatory Effects of Dopamine in Inflammatory Diseases. Front Immunol. 2021; 12:663102. PMC: 8063048. DOI: 10.3389/fimmu.2021.663102. View